Who Paid My Doc
Fluad Quadrivalent
Biological Vaccines
NDC 70461-121-03
General payments
$89,292
Research payments
$162,261
Through program year 2023, $89,292 in general payments and $162,261 in research payments were reported against Fluad Quadrivalent (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $31,633 | 1,697 |
| 2023 | Research | $3,000 | 2 |
| 2022 | General | $46,989 | 1,943 |
| 2021 | General | $10,671 | 657 |
| 2021 | Research | $159,261 | 113 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 59 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
4,297 general · 115 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.